(Q42807495)

7 November 2017

A bioassay for the measurement of human interleukin-4 (English)

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

2 November 2022

0 references

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

2 November 2022

author name string

J. P. Siegel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698879

2 November 2022

H. S. Mostowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1698879

2 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1698879

2 November 2022

publication date

1 September 1990

1 reference

7 November 2017

14 September 1990

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1698879

full work available at URL

2 November 2022

https://api.elsevier.com/content/article/PII:0022175990900403?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

https://api.elsevier.com/content/article/PII:0022175990900403?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Journal of Immunological Methods

2 November 2022

published in

1 reference

7 November 2017

132

1 reference

7 November 2017

287-295

1 reference

7 November 2017

2

1 reference

describes a project that uses

7 November 2017

Ramos.2G6.4C10

0 references

cites work

Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4

1

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies

2 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.

2 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves

2 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Effect of tumor necrosis factor alpha on mitogen-activated human B cells

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Lymphotoxin is an important T cell-derived growth factor for human B cells

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Application of a human T cell line derived from a Sézary syndrome patient for human interleukin 4 assay.

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells

2 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

2 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0022-1759(90)90040-3

2 November 2022

Identifiers

1 reference

7 November 2017

1 reference